Skip to main content
Clinical Trials/NCT02449070
NCT02449070
Unknown
Phase 3

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction : A Randomized Clinical Trial

Pusan National University Hospital1 site in 1 country86 target enrollmentMay 2015
InterventionsNicorandil

Overview

Phase
Phase 3
Intervention
Nicorandil
Conditions
Myocardial Infarction
Sponsor
Pusan National University Hospital
Enrollment
86
Locations
1
Primary Endpoint
Infarct size as measured by cardiac MRI
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to determine whether nicorandil reduce cardiac infarct size in patient with ST-segment elevation acute myocardial infarction.

Detailed Description

Study objective : To investiage whether nicorandil treatment reduce infarct size measured by cardiac MRI at 6 months after primary PCI Allocation : 1. Nicorandil arm : Recieve nicorandil 4 mg i.v. before undergoing PCI, additionall 2mg i.c. just before 1st ballooning, additionall 2mg i.c. just before stenting, After successful PCI, 10 mg/day (or 5 mg/day) p.o. for 6 months. 2. Control arm : Recieve standard treatment including PCI, but avoid nicoranil and adenosine. Follow-up and Measurement : Cardiac MRI scans are scheduled at 5 days and 6 months after primary PCI. Clinically followed upto 6 months after parimary PCI.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
October 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jun-Hyok OH

Assistant professor

Pusan National University Hospital

Eligibility Criteria

Inclusion Criteria

  • STEMI patients presenting within 12 hours after symptom onset
  • Undergoing primary PCI

Exclusion Criteria

  • Previous myocardial infarction
  • Atrial fibrillation
  • RV infarction
  • Cardiogenic shock
  • Serum creatinine \>2.0 mg/dL
  • Narrow angle glaucoma
  • Taking PDE-5 inhibitors

Arms & Interventions

Nicorandil

Receive nicorandil before primary PCI and thereafter for 6 months along with the standard therapy.

Intervention: Nicorandil

Outcomes

Primary Outcomes

Infarct size as measured by cardiac MRI

Time Frame: Six months after primary PCI

Secondary Outcomes

  • ST-segment resolution(One hour after primary PCI)
  • MVO as measured by cardiac MRI(Five days after primary PCI)
  • LVEF(%) as measured by cardiac MRI(Five days and 6 months after primary PCI)
  • MACE (Death, Spontaneous MI, Stroke)(up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials